PHARMAN
ActiveSummary
PHARMAN has been active since 1998 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €340,968 and a net result of €49,709. Equity is growing by about 22% per year across the filed financial years. Its solvency ranks better than 49% of 9,585 sector peers (NACE 82, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Articles of association
- Other provisionsOther rules from the articles that fall under none of the themes above.
- Other provision: “Bestemming winst-reserves-interimdividenden, artikelen 5:142 en 5:143” (deed in Dutch)Other provision: “Wijze communicatie naar vennootschap toe, communicatie via dit adres geacht geldig” (deed in Dutch)1 more provision in the deed, see the deed of 22-01-2024
Read from the deeds: 3 provisions, deed of 22-01-2024